Aidoc, a global leader in clinical AI, has raised $150 million in Series E funding led by Growth Equity at Goldman Sachs Alternatives. The round had participation from General Catalyst, SoftBank Investment Advisors and NVentures (NVIDIA's venture capital arm). The round brings total funding to over $500 million, less than a year after a growth round led by General Catalyst and Square Peg. This underscores the pace of Aidoc's momentum and the accelerating demand for enterprise-scale clinical AI.